Patents by Inventor Wendy Huang Chern

Wendy Huang Chern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220362226
    Abstract: Disclosed herein are topical pharmaceutical compositions of Sebacoyl Dinalbuphine Ester (SDE) and methods of using such compositions for treating pruritus, pain, and inflammatory conditions.
    Type: Application
    Filed: April 29, 2022
    Publication date: November 17, 2022
    Inventors: Wendy Huang CHERN, Chan-Jung LI, Shu-Wen KUO, David Chih-Kuang CHOU, Yu-En TIEN
  • Publication number: 20190298702
    Abstract: Disclosed herein are topical pharmaceutical compositions of Sebacoyl Dinalbuphine Ester (SDE) and methods of using such compositions for treating pruritus, pain, and inflammatory conditions.
    Type: Application
    Filed: March 28, 2019
    Publication date: October 3, 2019
    Inventors: Wendy Huang Chern, Chan-Jung Li, Shu-Wen Kuo, David Chih-Kuang Chou, Yu-En Tien
  • Patent number: 9062037
    Abstract: The presently described subject matter relates to new derivatives of tazarotene that also exhibit retinoid activity, pharmaceutical compositions comprising the derivatives, method of treating skin disorders with the pharmaceutical compositions, and process of making the derivatives.
    Type: Grant
    Filed: August 20, 2014
    Date of Patent: June 23, 2015
    Assignee: Stiefel Laboratories, Inc.
    Inventors: Xue Ge, Hansen Wong, Wendy Huang Chern, Hans Hofland, Michael J. Bishop, Xin Frank Cai, Alan Colborn
  • Publication number: 20140357669
    Abstract: The presently described subject matter relates to new derivatives of tazarotene that also exhibit retinoid activity, pharmaceutical compositions comprising the derivatives, method of treating skin disorders with the pharmaceutical compositions, and process of making the derivatives.
    Type: Application
    Filed: August 20, 2014
    Publication date: December 4, 2014
    Inventors: Xue GE, Hansen WONG, Wendy Huang CHERN, Hans HOFLAND, Michael J. BISHOP, Xin Frank CAI, Alan COLBORN
  • Publication number: 20140357672
    Abstract: The presently described subject matter relates to new derivatives of tazarotene that also exhibit retinoid activity, pharmaceutical compositions comprising the derivatives, method of treating skin disorders with the pharmaceutical compositions, and process of making the derivatives.
    Type: Application
    Filed: August 20, 2014
    Publication date: December 4, 2014
    Inventors: Xue GE, Hansen WONG, Wendy Huang CHERN, Hans HOFLAND, Michael J. BISHOP, Xin Frank CAI, Alan COLBORN
  • Publication number: 20140249143
    Abstract: Provided are certain compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections.
    Type: Application
    Filed: October 19, 2012
    Publication date: September 4, 2014
    Applicant: GlaxoSmithKline LLC
    Inventors: Anna Lindsey Banka, Janos Botyanszki, Eric Gregory Burroughs, John George Catalano, Wendy Huang Chern, Hamilton D. Dickson, Margaret J. Gartland, Robert Hamatake, Hans Hofland, Jesse Daniel Keicher, Christopher Brooks Moore, John Bradford Shotwell, Matthew David Tallant, Jean-Philippe Therrien, Shihyun You
  • Publication number: 20120115909
    Abstract: The presently described subject matter relates to new derivatives of tazarotene that also exhibit retinoid activity, pharmaceutical compositions comprising the derivatives, method of treating skin disorders with the pharmaceutical compositions, and process of making the derivatives.
    Type: Application
    Filed: July 16, 2010
    Publication date: May 10, 2012
    Inventors: Xue Ge, Hansen Wong, Wendy Huang Chern, Hans Hofland, Michael J. Bishop, Xin Frank Cai, Alan Colborn